{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:37:28Z","timestamp":1761489448786},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T00:00:00Z","timestamp":1410998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10072-014-1945-8","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T13:28:19Z","timestamp":1410960499000},"page":"269-274","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography"],"prefix":"10.1007","volume":"36","author":[{"given":"Hae-Won","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooyeoun","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"key":"1945_CR1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mds.20806","volume":"21","author":"MT Barbosa","year":"2006","unstructured":"Barbosa MT, Caramelli P, Maia DP et al (2006) Parkinsonism and Parkinson\u2019s disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord 21:800\u2013808","journal-title":"Mov Disord"},{"key":"1945_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.10362","volume":"18","author":"J Benito-Leon","year":"2003","unstructured":"Benito-Leon J, Bermejo-Pareja F, Rodriguez J et al (2003) Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 18:267\u2013274","journal-title":"Mov Disord"},{"key":"1945_CR3","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/mds.22805","volume":"24","author":"HW Shin","year":"2009","unstructured":"Shin HW, Kim MJ, Kim JS et al (2009) Levosulpiride-induced movement disorders. Mov Disord 24:2249\u20132253","journal-title":"Mov Disord"},{"key":"1945_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mds.870130313","volume":"13","author":"JF Marti-Masso","year":"1998","unstructured":"Marti-Masso JF, Poza JJ (1998) Cinnarizine-induced parkinsonism: ten years later. Mov Disord 13:453\u2013456","journal-title":"Mov Disord"},{"key":"1945_CR5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00007611-198912000-00033","volume":"82","author":"KD Sethi","year":"1989","unstructured":"Sethi KD, Patel B, Meador KJ (1989) Metoclopramide-induced parkinsonism. South Med J 82:1581\u20131582","journal-title":"South Med J"},{"key":"1945_CR6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0140-6736(84)91516-2","volume":"2","author":"PJ Stephen","year":"1984","unstructured":"Stephen PJ, Williamson J (1984) Drug-induced parkinsonism in the elderly. Lancet 2:1082\u20131083","journal-title":"Lancet"},{"key":"1945_CR7","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/brain\/awr177","volume":"134","author":"JL Cummings","year":"2011","unstructured":"Cummings JL, Henchcliffe C, Schaier S et al (2011) The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134:3146\u20133166","journal-title":"Brain"},{"key":"1945_CR8","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/mds.10592","volume":"18","author":"V Marshall","year":"2003","unstructured":"Marshall V, Grosset D (2003) Role of dopamine transporter imaging in routine clinical practice. Mov Disord 18:1415\u20131423","journal-title":"Mov Disord"},{"key":"1945_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2010.08.024","volume":"226","author":"G Masilamoni","year":"2010","unstructured":"Masilamoni G, Votaw J, Howell L et al (2010) (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism. Exp Neurol 226:265\u2013273","journal-title":"Exp Neurol"},{"key":"1945_CR10","first-page":"855","volume":"44","author":"MR Davis","year":"2003","unstructured":"Davis MR, Votaw JR, Bremner JD et al (2003) Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT. J Nucl Med 44:855\u2013861","journal-title":"J Nucl Med"},{"key":"1945_CR11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.archger.2012.05.001","volume":"56","author":"JS Kim","year":"2013","unstructured":"Kim JS, Oh YS, Kim YI et al (2013) Combined use of (123)I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study. Arch Gerontol Geriatr 56:124\u2013128","journal-title":"Arch Gerontol Geriatr"},{"key":"1945_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/tcrm.2007.3.1.149","volume":"3","author":"R Lozano","year":"2007","unstructured":"Lozano R, Concha MP, Montealegre A et al (2007) Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia. Ther Clin Risk Manag 3:149\u2013155","journal-title":"Ther Clin Risk Manag"},{"key":"1945_CR13","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.22098","volume":"23","author":"M Tinazzi","year":"2008","unstructured":"Tinazzi M, Ottaviani S, Isaias IU et al (2008) [123I]FP-CIT SPET imaging in drug-induced parkinsonism. Mov Disord 23:1825\u20131829","journal-title":"Mov Disord"},{"key":"1945_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG et al (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15:503\u2013510","journal-title":"Mov Disord"},{"issue":"Suppl 7","key":"1945_CR15","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10575","volume":"18","author":"E Tolosa","year":"2003","unstructured":"Tolosa E, Coelho M, Gallardo M (2003) DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord 18(Suppl 7):S28\u2013S33","journal-title":"Mov Disord"},{"key":"1945_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0193-953X(18)30744-5","volume":"7","author":"D Tarsy","year":"1984","unstructured":"Tarsy D (1984) Movement disorders with neuroleptic drug treatment. Psychiatr Clin North Am 7:453\u2013471","journal-title":"Psychiatr Clin North Am"},{"key":"1945_CR17","first-page":"1879","volume":"39","author":"J Booij","year":"1998","unstructured":"Booij J, Habraken JB, Bergmans P et al (1998) Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson\u2019s disease. J Nucl Med 39:1879\u20131884","journal-title":"J Nucl Med"},{"key":"1945_CR18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/01.WNL.0000145765.19094.94","volume":"63","author":"A Varrone","year":"2004","unstructured":"Varrone A, Pellecchia MT, Amboni M et al (2004) Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Neurology 63:2097\u20132103","journal-title":"Neurology"},{"key":"1945_CR19","doi-asserted-by":"crossref","unstructured":"Esper CD, Factor SA (2008) Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord 23(3):401\u2013404","DOI":"10.1002\/mds.21854"},{"key":"1945_CR20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.51.6.850","volume":"51","author":"RJ Hardie","year":"1988","unstructured":"Hardie RJ, Lees AJ (1988) Neuroleptic-induced Parkinson\u2019s syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51:850\u2013854","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1945_CR21","doi-asserted-by":"crossref","unstructured":"Goetz CG (1983) Drug-induced Parkinsonism and idiopathic Parkinson's disease. Arch Neurol 40:325\u2013326","DOI":"10.1001\/archneur.1983.04050050093019"},{"key":"1945_CR22","doi-asserted-by":"crossref","unstructured":"Garcia-Ruiz PJ, Garcia de Yebenes J, Jimenez-Jimenez FJ et al (1992) Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neuropharmacol 15(1):19\u201326","DOI":"10.1097\/00002826-199202000-00003"},{"key":"1945_CR23","doi-asserted-by":"crossref","unstructured":"Benvenuti F, Baroni A, Bandinelli S et al (1988) Flunarizine-induced parkinsonism in the elderly. J Clin Pharmacol 28(7):600\u2013608","DOI":"10.1002\/j.1552-4604.1988.tb03183.x"},{"key":"1945_CR24","doi-asserted-by":"crossref","unstructured":"Booij J, Kemp P (2008) Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 35(2):424\u2013438","DOI":"10.1007\/s00259-007-0621-0"},{"key":"1945_CR25","doi-asserted-by":"crossref","unstructured":"Nikolaus S, Antke C, Kley K et al (2010) Pretreatment with haloperidol reduces (123)I-FP-CIT binding to the dopamine transporter in the rat striatum: an in vivo imaging study with a dedicated small-animal SPECT camera. J Nucl Med 50(7):1147\u20131152","DOI":"10.2967\/jnumed.109.061952"},{"key":"1945_CR26","doi-asserted-by":"crossref","unstructured":"Mateos JJ, Lomena F, Parellada E et al (2005) Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism. Psychopharmacology (Berl) 181(2):401\u2013406","DOI":"10.1007\/s00213-005-2250-2"},{"key":"1945_CR27","doi-asserted-by":"crossref","unstructured":"Chen RC, Chang SF, Su CL et al (2001) Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology 57(9):1679\u20131686","DOI":"10.1212\/WNL.57.9.1679"},{"key":"1945_CR28","doi-asserted-by":"crossref","unstructured":"Li SC, Schoenberg BS, Wang CC et al (1985) A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol 42(7):655\u2013657","DOI":"10.1001\/archneur.1985.04060070045013"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-014-1945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-014-1945-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-014-1945-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T23:33:53Z","timestamp":1565825633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-014-1945-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1007\/s10072-014-1945-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,18]]}}}